Dr. Ann M. Geiger is Deputy Associate Director of the Healthcare Delivery Research Program within NCI’s Division of Cancer Control and Population Sciences. She also serves as the lead scientist for the cancer care delivery research component of the NCI Community Oncology Research Program. For two years she was Acting Associate Director of HDRP and was responsible for developing a scientific vision, establishing efficient operations, and nurturing a collegial culture for this new group. Before taking on the acting role, she was Chief of the Healthcare Assessment Research Branch and was responsible for a grant portfolio and research initiatives aimed at addressing questions related to access, utilization, diffusion, and outcome of health care in populations. In her various positions at NCI, Ann has promoted health services research to senior leaders at NCI and she has represented NCI on national initiatives such as the President’s Cancer Panel and the Access Work Stream of President Obama’s and Vice President Biden’s Cancer Moonshot.
Before joining NCI, Dr. Geiger worked in both academic and delivery system settings. She spent seven years on the faculty of Wake Forest University School of Medicine where, in addition to conducting research focused on cancer survivorship, she served as Co-Director of the Graduate Program in Clinical and Translational Sciences. Prior to her position at Wake Forest, Dr. Geiger was a scientist at Kaiser Permanente Southern California for ten years, where she collaborated with clinicians and institutional leaders to conduct practice-based research focused on cancer screening, treatment outcomes, and quality of life. She has co-authored over 100 publications and participated in numerous peer reviews of manuscripts and grant applications, as well as serving as an Associate Editor of the Journal of the National Cancer Institute since 2007. Dr. Geiger earned an A.B. in Biology from Harvard-Radcliffe College and a M.P.H. and Ph.D. in Epidemiologic Science from the University of Michigan.
Last Updated: 14 Sep 2018